Sequent Scientific Share Price

Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.As of 25 May 2026, Sequent Scientific share price is ₹260.96. The stock opened at ₹247.90, compared to its previous close of ₹246.06. During today's trading session, Sequent Scientific share price moved in the range of ₹247.90 to ₹262.00, with an average price of ₹254.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹247.90 and a high of ₹262.00. On the performance front, Sequent Scientific share price has increased by 17.57% over the last six months and is up 45.03% on a year-on-year basis.

The market capitalization of Sequent Scientific is ₹10,747 Crs, with a P/E ratio of 47.9 and a dividend yield of 0.00%.